Text Size
1 study found for:    NCT00676507

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Active, not recruiting Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Conditions: Lung Neoplasm;   Carcinoma Non-small Cell Lung Cancer Stage IIIA;   Carcinoma Non-small Cell Lung Cancer Stage IIIB;   Carcinoma Non-small Cell Lung Cancer Stage IV
Interventions: Biological: Lucanix™;   Other: Placebo Comparator
To Top

† Indicates status has not been verified in more than two years